ConductScience.org, home

Trial · NCT04218383

Transcranial Direct Current Stimulation for Impulsivity and Food-related Impulsivity in Obesity

NCT04218383, Not applicable, Suspended, University of Calgary

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Transcranial Direct Current Stimulation for Impulsivity and Food-related Impulsivity in Obesity. Trials, record NCT04218383. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04218383

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Transcranial Direct Current Stimulation for Impulsivity and Food-related Impulsivity in Obesity
NCT number
NCT04218383
Status
Suspended
Phases
Not applicable
Enrollment
30 participants, estimated
Lead sponsor
University of Calgary
Conditions
Impulsive Behavior
Interventions
Transcranial Direct Current Stimulation
First posted
2020-01-06
Last updated
2021-01-15

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryProbabilistic Decision MakingBefore and after a 20-minute tDCS sessionNet score of the Iowa Gambling Task The net score ranges from -20 to 30. Higher values represent a better outcome (i.e., enhanced decision-making)
SecondaryCognitive ControlBefore and after a 20-minute tDCS session
Interference index in the Stroop Color-word Task. Interference index is the reaction time computed between the presentation of the stimulus and the response of the participant. It typically ranges from 0 to 300 millisecond, with smaller values of reaction time indicate better outcome (i.e., better cognitive control).
SecondaryFood-specific cognitive controlBefore and after a 20-minute tDCS session
The interference index in the Food-Stroop Color-Word test. Interference index is the reaction time computed between the presentation of the stimulus and the response of the participant. It typically ranges from 0 to 300 millisecond, with smaller values of reaction time indicate better outcome (i.e., better Food-specific cognitive control).
SecondaryDelayed discountingBefore and after a 20-minute tDCS session
The discount rate for delayed monetary rewards. This rate is quantified by the hyperbolic discounting function using the following equation: V = A/(1+kD), where A presents the value of the delayed reward A at delay D, and k is a free parameter that determines the discount rate, with higher values of k indicate worse outcome (i.e., greater discounting of rewards as a function of time).
SecondaryMotor impulsivityBefore and after a 20-minute tDCS session.The stop-signal reaction time in the Stop-Signal Task. The stop signal reaction time ranges from 50 to 250, where greater values represent worse outcome (i.e, increased motor impulsivity).
SecondaryModeration of effect by self-reported measures of impulsivity and dysregulated eatingBefore and after a 20-minute tDCS session.
Individuals with high levels of impulsivity, impulsive eating, binge eating, self-reported food addiction will show greater moderation by tDCS on our primary and secondary outcomes. Barrat's impulsiveness scale-11 with a range of scores from 0 to 120, with higher scores indicating greater impulsivity. Reward-based eating drive scale-13 with a range of scores from 0 to 54, with higher scores indicating greater uncontrolled eating. Binge eating scale with a range of scores from 0 to 46: minimal binge eating ( \>17), moderate binge eating (18-26), and severe binge eating (\<27)). Yale Food Addiction Scale with a range of symptom severity from 0 to 7: mild (2-3 symptoms), moderate (4-5 symptoms), severe (6 or more symptoms)).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers16

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
8039375BACKGROUNDPubMed
9881538BACKGROUNDPubMed
11879657BACKGROUNDPubMed
12946886BACKGROUNDPubMed
16136173BACKGROUNDPubMed
17187897BACKGROUNDPubMed
17566768BACKGROUNDPubMed
17655972BACKGROUNDPubMed
19828708BACKGROUNDPubMed
20539296BACKGROUNDPubMed

1 to 10 of 16

See all 16 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Iowa Gambling LitePrimary outcomeConductCognition
Stop-Signal TaskSecondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04218383

GET https://conductscience.org/api/trials/v1/NCT04218383/registered